Natco settles patent litigation with Celgene on cancer drug

Natco and its US partner Allergan have settled a pending litigation with Celgene regarding generic Lenalidomide capsules used for treatment of multiple myeloma.
Source: The Economic Times - Category: Consumer Health News Source Type: news